Timing of Melanoma Immunotherapy Could Be Key to Outcomes: Study
MONDAY, March 6, 2023 (HealthDay News) — A tweak in timing may make an immune-system therapy much more effective for patients undergoing surgery for advanced melanoma, a new clinical trial has found. Researchers showed that giving the therapy — a drug called Keytruda (pembrolizumab) — both before and after surgeryContinue Reading